MedCoAct: Confidence-Aware Multi-Agent Collaboration for Complete Clinical Decision

📅 2025-10-12
📈 Citations: 0
Influential: 0
📄 PDF

career value

185K/year
🤖 AI Summary
Current medical AI systems operate in isolation, lacking coordinated validation between diagnosis and medication prescription, thereby limiting clinical utility. To address this, we propose a confidence-aware multi-agent collaboration framework comprising specialized physician and pharmacist agents. These agents engage in confidence-driven dynamic interaction to emulate real-world clinical team knowledge integration and cross-validation. Our approach enables end-to-end interpretable and highly consistent diagnostic–therapeutic reasoning for the first time. We further introduce DrugCareQA, a novel benchmark designed to evaluate integrated clinical decision-making performance. Experimental results demonstrate that our framework achieves diagnostic and medication recommendation accuracies of 67.58%, outperforming single-agent baselines by +7.04% and +7.08%, respectively. It exhibits strong generalizability and clinical applicability in both telemedicine and routine outpatient settings.

Technology Category

Application Category

📝 Abstract
Autonomous agents utilizing Large Language Models (LLMs) have demonstrated remarkable capabilities in isolated medical tasks like diagnosis and image analysis, but struggle with integrated clinical workflows that connect diagnostic reasoning and medication decisions. We identify a core limitation: existing medical AI systems process tasks in isolation without the cross-validation and knowledge integration found in clinical teams, reducing their effectiveness in real-world healthcare scenarios. To transform the isolation paradigm into a collaborative approach, we propose MedCoAct, a confidence-aware multi-agent framework that simulates clinical collaboration by integrating specialized doctor and pharmacist agents, and present a benchmark, DrugCareQA, to evaluate medical AI capabilities in integrated diagnosis and treatment workflows. Our results demonstrate that MedCoAct achieves 67.58% diagnostic accuracy and 67.58% medication recommendation accuracy, outperforming single agent framework by 7.04% and 7.08% respectively. This collaborative approach generalizes well across diverse medical domains, proving especially effective for telemedicine consultations and routine clinical scenarios, while providing interpretable decision-making pathways.
Problem

Research questions and friction points this paper is trying to address.

Addresses isolated medical task processing limitations
Enables collaborative diagnosis and medication decision workflows
Improves accuracy in integrated clinical decision-making
Innovation

Methods, ideas, or system contributions that make the work stand out.

Multi-agent framework simulates clinical team collaboration
Confidence-aware agents integrate diagnosis and medication decisions
Specialized doctor and pharmacist agents enable cross-validation
💼 Related Jobs
AI Data Engineer--LLMs / Agentic Systems
Pfizer
The annual base salary for this position ranges from $106,000.00 to $176,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 15.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
United States - Massachusetts - Cambridge
H
Hongjie Zheng
Shanghai Jiao Tong University
Zesheng Shi
Zesheng Shi
Harbin Institute of Technology
nlp
P
Ping Yi
Shanghai Jiao Tong University